News
Latest News
Washington, D.C. (September 16, 2020) — Today, Rep. James E.
Washington, D.C. (September 15, 2020) — Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, and Rep.
Washington, D.C. (September 14, 2020) — Today, all Democratic Members of the Select Subcommittee on the Coronavirus Crisis, led by Chairman James E.
Washington, D.C. (September 11, 2020) — Today, Rep. James E.
Washington, D.C. (Sept. 11, 2020)—Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, Rep. James E. Clyburn, the Chairman of the Select Subcommittee on the Coronavirus Crisis, and Rep.
Washington, D.C. (September 9, 2020) — Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E.
Washington, D.C. (September 8, 2020) — Today Rep. James E. Clyburn, Chair of the Select Subcommittee on the Coronavirus Crisis, issued the following statement in response to a pledge from chief executives of nine drug companies not to seek regulatory approval for experimental coronavirus vaccines until they have demonstrated safety and efficacy in Phase 3 clinical trials:
Washington, D.C. (September 4, 2020) — On Wednesday, September 9, 2020, at 1:00 p.m. ET, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E.
Washington, D.C. (September 1, 2020) — Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E.